William Richard White
CIK 1778739 · Chief Financial Officer · last filed 2026-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$119.4K
Companies
3
Total Filings
63
Lifetime Open-Market Net
-$19.12M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) Delisted | Director | 7,027 | $13.99 | $98.3K | -$1.17M | 8 | 2026-03-04 |
| Akero Therapeutics, Inc. (AKRO) Delisted | Chief Financial Officer | 0 | $54.65 | $0 | -$14.99M | 41 | 2025-12-09 |
| IRON | Director | 1,756 | $67.99 | $119.4K | -$2.96M | 13 | 2025-06-13 |
Recent Filings · Page 5 of 7
63 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-24 | Ventyx Biosciences, Inc. (VTYX) Delisted | Mixed | — | -$969.5K | EDGAR |
| 2023-01-03 | — | Grant (A) | — | $0 | |
| 2022-12-29 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$855.1K | EDGAR |
| 2022-12-20 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-13 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +19,195 | $0 | EDGAR |
| 2022-10-17 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$656.2K | EDGAR |
| 2022-09-15 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$650.5K | EDGAR |
| 2022-09-13 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +1,152 | $9.3K | EDGAR |
| 2022-06-10 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-18 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$145.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.